Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Omicron Variant and Monoclonal Antibody Treatments for COVID-19

Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.
Arthur Kim, MD
Released: February 21, 2022

Information on this Educational Activity

Faculty

Arthur Kim, MD

Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD, has disclosed that he is on the drug and safety monitoring board of Kintor.

Program Medium

This program has been made available online.

Related Content

Expert faculty provide a comprehensive overview of current landscape of outpatient COVID-19 management strategies, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Renslow Sherer, MD person default Trinh P. Vu, PharmD, BCIDP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 22, 2022 Expired: November 21, 2023

Expert faculty discuss ways to improve the empiric treatment of HABP/VABP in the ICU in this commentary from Clinical Care Options (CCO)

person default Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 18, 2022

Dr Alicia Lichvar: importance of COVID-19 prevention in patients with immunocompromise, from Clinical Care Options (CCO)

person default Alicia Lichvar, PharmD, MS, BCPS, BCTXP Released: November 17, 2022

Dr Joseph Torrisi answers key questions regarding treatment considerations for nonhospitalized patients with acute COVID-19, from Clinical Care Options (CCO)

Joseph Torrisi, PharmD, BCIDP Released: November 17, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings